SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 123 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $481,000 | -46.0% | 27,664 | -66.0% | 0.00% | -72.7% |
Q1 2020 | $891,000 | -0.4% | 81,248 | -20.3% | 0.01% | +22.2% |
Q4 2019 | $895,000 | +50.2% | 101,952 | +27.8% | 0.01% | +28.6% |
Q3 2019 | $596,000 | +100.0% | 79,744 | +149.0% | 0.01% | +75.0% |
Q2 2019 | $298,000 | +250.6% | 32,032 | +97.7% | 0.00% | +300.0% |
Q1 2019 | $85,000 | -55.5% | 16,200 | -62.3% | 0.00% | -66.7% |
Q4 2018 | $191,000 | -63.0% | 42,939 | -32.8% | 0.00% | -57.1% |
Q3 2018 | $516,000 | +79.8% | 63,915 | +56.6% | 0.01% | +40.0% |
Q2 2018 | $287,000 | – | 40,815 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |